SCHEMBL7976789

SCHEMBL7976789

O=C(O)CCCC(=O)NNC(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.59
TDP1 Q9NUW8 6/20 0.57
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
KDM4E B2RXH2 4/20 0.54
CTDSP1 Q9GZU7 2/20 0.54
DUSP3 P51452 1/20 0.54
PTPN5 P54829 1/20 0.54
PTPN11 Q06124 1/20 0.54
GAA P10253 1/20 0.53
ALDH1A1 P00352 2/20 0.53
LMNA P02545 1/20 0.53
MAPT P10636 2/20 0.53
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
HPGD P15428 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12323197 0.91 POLB (0.69) POLBTDP1MEN1KMT2AKDM4E
SCHEMBL12768686 0.89 POLB (0.67) POLBTDP1MEN1KMT2AKDM4E
SCHEMBL12768681 0.89 POLB (0.67) POLBTDP1MEN1KMT2AKDM4E
SCHEMBL12768688 0.89 POLB (0.67) POLBTDP1MEN1KMT2AKDM4E
SCHEMBL12768690 0.87 KDM4E (0.61) POLBTDP1MEN1KMT2AKDM4E
SCHEMBL10591379 0.84 POLB (0.75) POLBTDP1MEN1KMT2AKDM4E
SCHEMBL7263142 0.84 HDAC1 (0.52) MEN1KMT2AGAAALDH1A1LMNA
SCHEMBL6637333 0.81 POLB (0.81) POLBTDP1MEN1KMT2AGAA
SCHEMBL13454574 0.81 RAB9A (0.63) POLBTDP1MEN1KMT2AKDM4E
SCHEMBL13593267 0.80 L3MBTL1 (0.56) POLBMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001007409-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA UK LIMITED (GB) 2001-02-01 WO disclosed